NutraLife BioSciences, Inc. (NLBS)

Market Cap	3.36M
Revenue (ttm)	631,957
Net Income (ttm)	-5.28M
Shares Out	176.62M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,000
Open	0.0190
Previous Close	0.0190
Day's Range	0.0190 - 0.0190
52-Week Range	0.0150 - 0.1160
Beta	-1.04
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NLBS

NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. Nutra...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2010
• Employees: 12
• Stock Exchange: OTCMKTS
• Ticker Symbol: NLBS

Financial Performance

In 2021, NLBS's revenue was $626,619, a decrease of -50.10% compared to the previous year's $1.26 million. Losses were -$3.98 million, 4.50% more than in 2020.